David Apelian
2018 - Celladon
In 2018, David Apelian earned a total compensation of $2.5M as Chief Operating Officer at Celladon, a 183% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Option Awards | $1,739,306 |
| Salary | $514,076 |
| Other | $57,996 |
| Total | $2,491,378 |
Apelian received $1.7M in option awards, accounting for 70% of the total pay in 2018.
Apelian also received $180K in non-equity incentive plan, $514.1K in salary and $58K in other compensation.
Rankings
In 2018, David Apelian's compensation ranked 4,691st out of 14,244 executives tracked by ExecPay. In other words, Apelian earned more than 67.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,691 out of 14,244 | 67th |
Division Manufacturing | 1,766 out of 5,765 | 69th |
Major group Chemicals And Allied Products | 638 out of 2,128 | 70th |
Industry group Drugs | 536 out of 1,817 | 71st |
Industry Biological Products, Except Diagnostic Substances | 108 out of 339 | 68th |
Source: SEC filing on April 26, 2019.
Apelian's colleagues
We found two more compensation records of executives who worked with David Apelian at Celladon in 2018.